AIM
ANAB icon

Alambic Investment Management’s AnaptysBio ANAB Stock Holding History

Alambic Investment Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-20,800
Closed -$307K – 3
2020
Q3 		$307K Sell
20,800
-4,850
-19% -$87.5K 3.37% 6
2020
Q2 		$573K Sell
25,650
-6,425
-20% -$117K 1.44% 9
2020
Q1 		$453K Sell
32,075
-18,325
-36% -$278K 1.1% 17
2019
Q4 		$819K Buy
+50,400
New +$1.19M 0.69% 37

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Alambic Investment Management's ANAB Position: Q4 2020 in Review

Alambic Investment Management sold out of AnaptysBio (ANAB) in Q4 2020, closing a stake of 20,800 shares — an estimated $307K sold.

Alambic Investment Management first reported a position in ANAB in Q4 2019 and held it in 4 quarters. The position peaked at $819K in Q4 2019. 136 funds tracked by Wall St. Rank hold ANAB as of Q4 2020.

  • Alambic Investment Management reported no remaining AnaptysBio position as of Q4 2020 after selling out during the quarter.
  • Alambic Investment Management sold 20,800 AnaptysBio shares in Q4 2020, an estimated $307K.
  • Alambic Investment Management first reported a position in AnaptysBio in Q4 2019 and held it in 4 quarters.
  • Alambic Investment Management's AnaptysBio position peaked at $819K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2020.

Based on Alambic Investment Management's 13F filing for Q4 2020.